Immuneering Corporation (IMRX) Earnings
|
Expand Research on IMRX
| Next EPS Date | 11/5/26 | EPS Growth Rate | +21.1% |
|---|---|---|---|
| Average EPS % Beat Rate | +5.6% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +9.4% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/5/26  |
Q326 | N/A | -$0.30 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/5/26 |
Q226 | -$0.27 | -$0.27 | $0.00 | N/A | N/A | N/A |  | | Details | |
| 5/12/26 |
Q126 | N/A | -$0.25 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/11/26 |
Q425 | N/A | -$0.31 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/12/25 | Q325 | -$0.38 | -$0.41 | +$0.03 | N/A | N/A | N/A | | | Details | |
| 8/13/25 |
Q225 | -$0.40 | -$0.42 | +$0.02 | N/A | N/A | N/A | | | Details | |
| 8/6/25 |
Q225 | N/A | -$0.42 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/6/25 |
Q125 | -$0.44 | -$0.49 | +$0.05 | N/A | N/A | N/A | | | Details |
